Skip to content

IntravasCular Imaging-Guided Versus AngiogRaphy-GUided Drug-Eluting Stent Implantation for Fermoropopliteal Artery Disease, A feasibility study

IntravasCular Imaging-Guided Versus AngiogRaphy-GUided Drug-Eluting Stent Implantation for Fermoropopliteal Artery Disease, A feasibility study

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CRIS
Registry ID
KCT0005057
Enrollment
100
Registered
2020-05-27
Start date
2020-11-27
Completion date
Unknown
Last updated
2022-02-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Procedure/Surgery : In the IVUS-guided group, IVUS will be either automatically (1 mm/sec) or manually (5-10 mm/sec) pulled back at a constant speed according to the lesion length. Stent size and leng

Sponsors

Asan Medical Center
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. 20 years of age=85 years of age. 2. Intermittent claudication or tissue loss suitable for elective endovascular intervention (Rutherford category 2,3,4, or 5) 3. Significant native superficial femoral or proximal popliteal artery lesions suitable for stent implantation(residual angiographic stenosis =70% ). Restenotic lesions can be enrolled at least 12-month after the index procedure uding plain balloon or drug-coated balloon. 4. Total lesion length of 30 to 220 mm 5. Reference vessel diameter of 4 – 6 mm 6. The patient or fuardian agrees written conenst to the study protocol.

Exclusion criteria

Exclusion criteria: 1. Existence of a stent in the target vessel 2. Previous use of atherectomy device in the target vessel 3. Use of drug-coated balloon in the target vessel within 12-month 4. Significant stenosis or occlusion (diameter stenosis =70%) in all 3 infrapopliteal arteries 5. A known intolerance or contraindication to antiplatelet drugs (aspirin or clopidogrel)

Design outcomes

Primary

MeasureTime frame
peak systolic velocity ratio(peak systolic velocity ratio at the proximal and the distal portion of the implanted stent.) of 2.4 or lower as assessed by the duplex ultrasound;procedure related death;major amputation of the target limb or target-lesion revascularization

Secondary

MeasureTime frame
Technical success: deployment of the stent to the target lesion to achieve residual angiographic stenosis =30%;Procedural success: technical success without major adverse events

Countries

Korea, Republic of

Contacts

Public ContactGU DA SEUL

Asan Medical Center

gds9610@naver.com+82-2-2045-3798

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026